Eledon Pharmaceuticals
ELDN
ELDN
16 hedge funds and large institutions have $27.2M invested in Eledon Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
LSC
Lyon Street Capital
Sausalito,
California
|
-$389K |
2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$67K |
3 |
UBS Group
Zurich,
Switzerland
|
-$13K |
4 |
D.E. Shaw & Co
New York
|
-$6.58K |
5 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$1.5K |